You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 235 No. 3, January 19, 1976 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Meningococcal disease. Secondary attack rate and chemoprophylaxis in the United States, 1974


Three hundred twenty-six reported cases of meningococcal disease in the United States from November 1973 through March 1974 were investigated. Three household members became ill with meningococcal disease following onset of the initial case in their household. The secondary attack rate was approximately 3/1,000 household members. In 60% of the households, members were given an antimicrobial drug as chemoprophylaxis for meningococcal disease, but only 35% received minocycline hydrochloride or rifampin, the two drugs now available for the eradication of sulfonamide-resistant meningococci from the nasopharynx. Only 26% given chemoprophylaxis received the drug within 24 hours after the patient's hospital admission. Survey results indicate that the secondary attack rate of meningococcal disease may justify the use of chemoprophylaxis, but that frequently in the United States, the drugs given are likely to be ineffective, give too late, or administered to persons who are not at high risk to meningococcal disease.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Prospects for Vaccine Prevention of Meningococcal Infection
Harrison
Clin. Microbiol. Rev. 2006;19:142-164.
ABSTRACT | FULL TEXT  

Mutations in folP Associated with Elevated Sulfonamide MICs for Neisseria meningitidis Clinical Isolates from Five Continents
Fiebelkorn et al.
Antimicrob. Agents Chemother. 2005;49:536-540.
ABSTRACT | FULL TEXT  

Effectiveness of antibiotics in preventing meningococcal disease after a case: systematic review
Purcell et al.
BMJ 2004;328:1339.
ABSTRACT | FULL TEXT  

How Contagious Are Common Respiratory Tract Infections?
Musher
NEJM 2003;348:1256-1266.
FULL TEXT  

Improving promptness of antibiotic treatment in meningococcal disease
Riordan
Emerg. Med. J. 2001;18:162-163.
ABSTRACT | FULL TEXT  

Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management
van Deuren et al.
Clin. Microbiol. Rev. 2000;13:144-166.
ABSTRACT | FULL TEXT  

Meningococcal Disease in a Large Urban Population (Barcelona, 1987-1992): Predictors of Dismal Prognosis
Barquet et al.
Arch Intern Med 1999;159:2329-2340.
ABSTRACT | FULL TEXT  

Which contacts of patients with meningococcal disease carry the pathogenic strain of Neisseria meningitidis? A population based study
Kristiansen et al.
BMJ 1998;317:621-625.
ABSTRACT | FULL TEXT  

Prevention of Invasive Group A Streptococcal Disease Among Household Contacts of Case-Patients: Is Prophylaxis Warranted?
The Working Group on Prevention of Invasive Group
JAMA 1998;279:1206-1210.
ABSTRACT | FULL TEXT  

Meningococcal Disease and Public Health Practice: A Complicated Road Map
Moore and Osterholm
JAMA 1998;279:472-473.
FULL TEXT  

Meningococcal Disease in Los Angeles County, California, and among Men in the County Jails
Tappero et al.
NEJM 1996;335:833-841.
ABSTRACT | FULL TEXT  

Invasive Group A Streptococcal Infections in Ontario, Canada
Davies et al.
NEJM 1996;335:547-554.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1976 American Medical Association. All Rights Reserved.